Sponsor

Samyang Biopharmaceuticals Corporation

Clinical research sponsor

Published trials5

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

5 shown

Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast CancerNCT05207514 · lead sponsor · 2022-03-31

TERMINATED

Study to Evaluate the Safety of Nanoxel M Inj.NCT04066335 · lead sponsor · 2019-09-18

UNKNOWN

Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast CancerNCT00876486 · lead sponsor · 2008-12-01

COMPLETED

A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung CancerNCT01023347 · lead sponsor · 2008-06-01

COMPLETED

Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast CancerNCT02263495 · collaborator · 2014-12-19

COMPLETED

Sponsor roles

lead sponsor4

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.